Bafna Pharmaceuticals Limited
BAFNAPH
Rank in Stocks
#18572
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical... Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.
Share Price
$5.13
Last synced: 2026-11-11
Market Cap
$128.52M
Change (1 day)
2.01%
Change (1 year)
151.32%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bafna Pharmaceuticals Limited (BAFNAPH)
Category
Healthcare
Operating Margin for Bafna Pharmaceuticals Limited (BAFNAPH)
Operating Margin as of November 2026 TTM: 9.88%
According to Bafna Pharmaceuticals Limited's latest financial reports, its current operating margin (TTM) is 9.88%. At the end of 2025 the company had an operating margin of 4.31%.
Operating Margin history for Bafna Pharmaceuticals Limited from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 9.88% | 129.23% |
| 2025 | 4.31% | -72.35% |
| 2024 | 15.59% | 73.03% |
| 2023 | 9.01% | 18.09% |
| 2022 | 7.63% | -7.18% |
| 2021 | 8.22% | -277.92% |
| 2020 | -4.62% | -70.61% |
| 2019 | -15.72% | -42.10% |
| 2018 | -27.15% | -13.40% |
| 2017 | -31.35% | 74.55% |
| 2016 | -17.96% | 344.55% |
| 2015 | -4.04% | -401.49% |
| 2014 | 1.34% | -57.05% |
| 2013 | 3.12% | -70.98% |
| 2012 | 10.75% | 16.85% |
| 2011 | 9.20% | 1.10% |
| 2010 | 9.10% | -17.20% |
| 2009 | 10.99% | 131.37% |
| 2008 | 4.75% | 4.17% |
| 2007 | 4.56% | 146.49% |
| 2006 | 1.85% | -51.95% |
| 2005 | 3.85% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 59.80% | -93.95% |
US
|
|
| 31.60% | -96.80% |
SE
|
|
| 30.13% | -96.95% |
FR
|
|
| 29.76% | -96.99% |
HK
|
|
| 31.11% | -96.85% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bafna Pharmaceuticals Limited's operating margin
What is Bafna Pharmaceuticals Limited's operating margin?
Bafna Pharmaceuticals Limited's operating margin is 9.88%, as of Nov 2026.
What was Bafna Pharmaceuticals Limited's operating margin in 2025?
In 2025, Bafna Pharmaceuticals Limited's operating margin was 4.31%, compared with 15.59% in 2024.
How has Bafna Pharmaceuticals Limited's operating margin changed since 2020?
From 2020 to 2025, Bafna Pharmaceuticals Limited's operating margin was highest in 2024 (15.59%) and lowest in 2020 (-4.62%).
How does Bafna Pharmaceuticals Limited's operating margin compare with similar companies?
Bafna Pharmaceuticals Limited's operating margin (9.88%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 59.80%.